Westpac Banking Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.12M Sell
253,485
-4,505
-2% -$120K 0.49% 41
2025
Q4
$6.42M Sell
257,990
-4,886
-2% -$123K 0.41% 48
2025
Q3
$6.7M Buy
262,876
+36,846
+16% +$909K 0.42% 57
2025
Q2
$5.48M Buy
226,030
+35,422
+19% +$826K 0.37% 67
2025
Q1
$4.83M Buy
190,608
+87,937
+86% +$2.3M 0.36% 69
2024
Q4
$2.72M Buy
102,671
+28,473
+38% +$772K 0.18% 131
2024
Q3
$2.15M Buy
74,198
+18,225
+33% +$532K 0.14% 157
2024
Q2
$1.57M Buy
55,973
+2,946
+6% +$81.1K 0.12% 153
2024
Q1
$1.47M Sell
53,027
-949
-2% -$26.3K 0.11% 176
2023
Q4
$1.55M Sell
53,976
-40,616
-43% -$1.23M 0.13% 166
2023
Q3
$3.14M Buy
94,592
+44,699
+90% +$1.58M 0.23% 99
2023
Q2
$1.83M Sell
49,893
-998,441
-95% -$38.9M 0.13% 187
2023
Q1
$42.8M Buy
1,048,334
+143,214
+16% +$6.19M 0.58% 22
2022
Q4
$46.4M Buy
905,120
+182,817
+25% +$8.76M 0.69% 17
2022
Q3
$31.6M Sell
722,303
-72,765
-9% -$3.54M 0.48% 30
2022
Q2
$41.7M Sell
795,068
-35,485
-4% -$1.81M 0.54% 23
2022
Q1
$43M Buy
830,553
+64,189
+8% +$3.33M 0.49% 27
2021
Q4
$45.3M Buy
766,364
+104,043
+16% +$5.15M 0.47% 33
2021
Q3
$28.5M Sell
662,321
-171,565
-21% -$7.6M 0.3% 72
2021
Q2
$32.7M Sell
833,886
-17,659
-2% -$687K 0.33% 62
2021
Q1
$30.9M Buy
851,545
+23,300
+3% +$827K 0.34% 65
2020
Q4
$30.5M Sell
828,245
-15,955
-2% -$585K 0.35% 60
2020
Q3
$29.4M Buy
844,200
+18,481
+2% +$648K 0.4% 49
2020
Q2
$25.6M Sell
825,719
-160,178
-16% -$5.44M 0.38% 54
2020
Q1
$30.5M Buy
985,897
+6,082
+0.6% +$207K 0.53% 25
2019
Q4
$36.4M Sell
979,815
-8,612
-0.9% -$307K 0.47% 32
2019
Q3
$33.7M Sell
988,427
-101,189
-9% -$3.68M 0.47% 36
2019
Q2
$44.8M Buy
1,089,616
+124,375
+13% +$4.94M 0.68% 22
2019
Q1
$38.9M Buy
965,241
+185,641
+24% +$7.43M 0.64% 29
2018
Q4
$32.3M Buy
779,600
+84,287
+12% +$3.5M 0.55% 32
2018
Q3
$29.1M Buy
695,313
+61,379
+10% +$2.36M 0.5% 39
2018
Q2
$21.8M Sell
633,934
-73,569
-10% -$2.51M 0.42% 59
2018
Q1
$23.8M Buy
707,503
+33,892
+5% +$1.17M 0.48% 49
2017
Q4
$23.1M Buy
673,611
+29,550
+5% +$1.01M 0.53% 36
2017
Q3
$21.8M Buy
644,061
+36,911
+6% +$1.19M 0.48% 42
2017
Q2
$19.3M Sell
607,150
-681,218
-53% -$21.5M 0.43% 47
2017
Q1
$41.8M Buy
1,288,368
+219,507
+21% +$6.92M 0.34% 72
2016
Q4
$36.9M Buy
1,068,861
+46,864
+5% +$1.43M 0.35% 75
2016
Q3
$32.8M Sell
1,021,997
-285,518
-22% -$9.55M 0.35% 64
2016
Q2
$41.4M Sell
1,307,515
-150,811
-10% -$4.81M 0.45% 42
2016
Q1
$41M Sell
1,458,326
-860,772
-37% -$24.6M 0.45% 41
2015
Q4
$71M Sell
2,319,098
-61,636
-3% -$1.94M 0.79% 29
2015
Q3
$70.9M Buy
2,380,734
+446,027
+23% +$14.3M 0.78% 25
2015
Q2
$61.5M Sell
1,934,707
-226,247
-10% -$7.37M 0.6% 32
2015
Q1
$81M Buy
2,160,954
+26,125
+1% +$831K 0.7% 28
2014
Q4
$63.1M Sell
2,134,829
-156,308
-7% -$4.48M 0.6% 30
2014
Q3
$64.3M Sell
2,291,137
-24,357
-1% -$684K 0.63% 31
2014
Q2
$65.2M Sell
2,315,494
-158,425
-6% -$4.52M 0.63% 30
2014
Q1
$75.4M Buy
2,473,919
+709,460
+40% +$21.2M 0.8% 32
2013
Q4
$51.3M Sell
1,764,459
-42,610
-2% -$1.24M 0.59% 33
2013
Q3
$49.2M Sell
1,807,069
-179,551
-9% -$4.89M 0.62% 33
2013
Q2
$53.7M Buy
+1,986,620
New +$54.9M 0.82% 19

Other funds holding PFE

Westpac Banking Corp's PFE Position: Q1 2026 in Review

Westpac Banking Corp reduced its Pfizer (PFE) stake by 1.7% in Q1 2026, selling an estimated $120K and leaving 253,485 shares worth $7.12M. The position accounts for 0.49% of the portfolio, ranked #41.

Westpac Banking Corp first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $81M in Q1 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Westpac Banking Corp held 253,485 shares of Pfizer worth $7.12M as of Q1 2026.
  • Westpac Banking Corp sold 4,505 Pfizer shares in Q1 2026, an estimated $120K.
  • Pfizer made up 0.49% of Westpac Banking Corp's portfolio in Q1 2026, its #41 holding.
  • Westpac Banking Corp first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Pfizer position peaked at $81M in Q1 2015.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.